Clinical Trial Update: Avo In R/R And Previously Untreated MCL [Phase 1, Phase 2]

View source ↗

Summary

The trial is currently recruiting for an agent named Avo in mantle cell lymphoma, including relapsed/refractory disease and previously untreated cases, across P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Mantle Cell Lymphoma

Snippet

Sponsor: Austin I Kim | Conditions: Mantle Cell Lymphoma, Refractory Lymphoma | Phase 1, Phase 2 | Status: RECRUITING